Highbridge Capital Management LLC Vbi Vaccines Inc Transaction History

Highbridge Capital Management LLC

  • $435 Million
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018
SELL
$2.75 - $3.85 $687,500 - $962,500
-250,000 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$3.29 - $5.03 $822,500 - $1.26 Million
250,000
250,000 $1.07 Million

Others Institutions Holding VBIV

# of Institutions
2
Shares Held
688K
Call Options Held
0
Put Options Held
0
View Full List

About VBI Vaccines Inc

VBIV Quotes by TradingView
  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Highbridge Capital Management LLC Portfolio

Follow Highbridge Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highbridge Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email